Biopharmaceutical drugs in Germany 2008-2022, by stage of development

Published by
Kasia Davies,
Jan 29, 2024
This statistic shows the number of biopharmaceutical drugs developed in Germany from 2008 to 2022, by phase. In 2022, 282 biopharmaceutical drugs were in the first clinical phase. This was an increase compared to the previous year.

Number of biopharmaceutical drugs in development in Germany from 2008 to 2022, by phase

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

July 2023

Region

Germany

Survey time period

2008 to 2022

Supplementary notes

Phase l / lla included in Phase I; active substances in the authorization procedure contained in Phase II; active ingredients in studies conducted worldwide by companies operating in Germany.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Biotechnology in Germany "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Biotechnology in Germany

Overview

8

Biopharmaceutical market

8

Research and components

6

Funding

4

Occupation

3

Further related statistics

15

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology industry in Germany Global pharmaceutical industryBiotech drugs
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu